Phosphorus-32 (32P) radiopharmaceutical
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Phosphorus-32 (32P) radiopharmaceutical, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Observational Clinical Study on Exploring the Value of Surgical Excision Combined With 32P Application in the Treatment of Keloids and the Factors Affecting the Prognosis of Combined Therapy